Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/5/25 16:20 | 6/4/25 | LQDA | Health | Drug | Pharmaceutical Preparations | Schundler Russell | NC | O | GC | 12 | S.d | -697 | 13.82 | 0 | -50 | 597 | D | |||||||||||||||
6/5/25 16:20 | 6/4/25 | LQDA | Health | Drug | Pharmaceutical Preparations | Moomaw Scott | NC | O | Chief Co | 13 | S.d | -460 | 14.13 | 0 | -33 | 225 | D | |||||||||||||||
6/5/25 16:19 | 6/4/25 | LQDA | Health | Drug | Pharmaceutical Preparations | Saggar Rajeev | NC | O | Chief Me | 12 | S.d | -575 | 13.92 | 0 | -41 | 273 | D | |||||||||||||||
6/5/25 16:18 | 6/4/25 | LQDA | Health | Drug | Pharmaceutical Preparations | Jeffs Roger | NC | DO | CEO | 7 | S.d | -1,739 | 14.47 | 0 | -120 | 2,633 | D | |||||||||||||||
6/5/25 16:18 | 6/4/25 | LQDA | Health | Drug | Pharmaceutical Preparations | Kaseta Michael | NC | O | CFO,COO | 12 | S.d | -1,035 | 13.89 | 0 | -75 | 412 | D | |||||||||||||||
6/5/25 16:15 | 6/4/25 | LQDA | Health | Drug | Pharmaceutical Preparations | Adair Jason | NC | O | Chief Bu | 18 | S.d | -342 | 13.82 | 0 | -25 | 194 | D | |||||||||||||||
9/4/24 17:51 | 8/30/24 | LQDA | Health | Drug | Pharmaceutical Preparations | Caligan Partners LP | NY | DTH | See Rema | 1 | S | -1,427 | 9.51 | 0 | -150 | 14,010 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |